成大生物聘任33岁投行精英李业基为新董秘

Group 1 - The core point of the news is the personnel adjustment at Chengda Biological, with the resignation of the former board secretary Cui Jianwei and the appointment of Li Yeji as the new board secretary [1][3] - Cui Jianwei will continue to serve as a director, deputy general manager, and chief financial officer, indicating that his experience in financial and business management will still contribute to the company's strategic development [3] - Li Yeji, born in October 1992, has a strong educational background and extensive experience in investment banking and asset management, which may align with the company's future capital operation needs [3] Group 2 - The personnel change occurs against the backdrop of a significant shift in Chengda Biological's control structure, with the indirect controlling shareholder changing from the Liaoning State-owned Assets Supervision and Administration Commission to a state of no actual controller [3] - The new controlling shareholder, Shaoguan Gaoteng Enterprise Management Co., Ltd., gained control through board seat advantages, although this change did not directly lead to management turmoil [3] - Market analysis suggests that the new board secretary's investment banking background may be related to the company's future capital operation requirements [3]